BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 22574992)

  • 21. Design, synthesis and anticancer evaluation of novel tetrahydroquinoline derivatives containing sulfonamide moiety.
    Ghorab MM; Ragab FA; Hamed MM
    Eur J Med Chem; 2009 Oct; 44(10):4211-7. PubMed ID: 19540022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis and in vitro and in vivo antitumor activities of novel bivalent β-carbolines.
    Shi B; Cao R; Fan W; Guo L; Ma Q; Chen X; Zhang G; Qiu L; Song H
    Eur J Med Chem; 2013 Feb; 60():10-22. PubMed ID: 23279863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and antitumoral activity of novel 3-(2-substituted-1,3,4-oxadiazol-5-yl) and 3-(5-substituted-1,2,4-triazol-3-yl) beta-carboline derivatives.
    Formagio AS; Tonin LT; Foglio MA; Madjarof C; de Carvalho JE; da Costa WF; Cardoso FP; Sarragiotto MH
    Bioorg Med Chem; 2008 Nov; 16(22):9660-7. PubMed ID: 18951806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and biological evaluation of novel 3,9-substituted β-carboline derivatives as anticancer agents.
    Chen YF; Lin YC; Chen JP; Chan HC; Hsu MH; Lin HY; Kuo SC; Huang LJ
    Bioorg Med Chem Lett; 2015 Sep; 25(18):3873-7. PubMed ID: 26235951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and evaluation of 9-anilinothiazolo[5,4-b]quinoline derivatives as potential antitumorals.
    Rodríguez-Loaiza P; Quintero A; Rodríguez-Sotres R; Solano JD; Lira-Rocha A
    Eur J Med Chem; 2004 Jan; 39(1):5-10. PubMed ID: 14987829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liposomal formulation of DIMIQ, potential antitumor indolo[2,3-b]quinoline agent and its cytotoxicity on hepatoma Morris 5123 cells.
    Jaromin A; Kozubek A; Suchoszek-Lukaniuk K; Malicka-Blaszkiewicz M; Peczynska-Czoch W; Kaczmarek L
    Drug Deliv; 2008 Jan; 15(1):49-56. PubMed ID: 18197524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and antitumor evaluation of new thiazolo[5,4-b]quinoline derivatives.
    Alvarez-Ibarra C; Fernández-Granda R; Quiroga ML; Carbonell A; Cárdenas F; Giralt E
    J Med Chem; 1997 Feb; 40(5):668-76. PubMed ID: 9057853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, in vitro and in vivo biological evaluation, and comprehensive understanding of structure-activity relationships of dipeptidyl boronic acid proteasome inhibitors constructed from β-amino acids.
    Zhu Y; Wu G; Zhu X; Ma Y; Zhao X; Li Y; Yuan Y; Yang J; Yu S; Shao F; Lei M
    J Med Chem; 2010 Dec; 53(24):8619-26. PubMed ID: 21077681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis and evaluation of cytotoxicity of novel chromeno[4,3-b]quinoline derivatives.
    Miri R; Motamedi R; Rezaei MR; Firuzi O; Javidnia A; Shafiee A
    Arch Pharm (Weinheim); 2011 Feb; 344(2):111-8. PubMed ID: 21290427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, molecular modeling and biological evaluation of 2-aminomethyl-5-(quinolin-2-yl)-1,3,4-oxadiazole-2(3H)-thione quinolone derivatives as novel anticancer agent.
    Sun J; Zhu H; Yang ZM; Zhu HL
    Eur J Med Chem; 2013 Feb; 60():23-8. PubMed ID: 23279864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The synthesis of indolo[2,3-b]quinoline derivatives with a guanidine group: highly selective cytotoxic agents.
    Sidoryk K; Świtalska M; Jaromin A; Cmoch P; Bujak I; Kaczmarska M; Wietrzyk J; Dominguez EG; Żarnowski R; Andes DR; Bańkowski K; Cybulski M; Kaczmarek Ł
    Eur J Med Chem; 2015 Nov; 105():208-19. PubMed ID: 26496013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biological evaluation of omega-(dialkylamino)alkyl derivatives of 6H-indolo[2,3-b]quinoline--novel cytotoxic DNA topoisomerase II inhibitors.
    Godlewska J; Luniewski W; Zagrodzki B; Kaczmarek L; Bielawska-Pohl A; Dus D; Wietrzyk J; Opolski A; Siwko M; Jaromin A; Jakubiak A; Kozubek A; Peczyñska-Czoch W
    Anticancer Res; 2005; 25(4):2857-68. PubMed ID: 16080538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of some cryptolepine analogues, assessment of their antimalarial and cytotoxic activities, and consideration of their antimalarial mode of action.
    Onyeibor O; Croft SL; Dodson HI; Feiz-Haddad M; Kendrick H; Millington NJ; Parapini S; Phillips RM; Seville S; Shnyder SD; Taramelli D; Wright CW
    J Med Chem; 2005 Apr; 48(7):2701-9. PubMed ID: 15801861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimization of 6,7-disubstituted-4-(arylamino)quinoline-3-carbonitriles as orally active, irreversible inhibitors of human epidermal growth factor receptor-2 kinase activity.
    Tsou HR; Overbeek-Klumpers EG; Hallett WA; Reich MF; Floyd MB; Johnson BD; Michalak RS; Nilakantan R; Discafani C; Golas J; Rabindran SK; Shen R; Shi X; Wang YF; Upeslacis J; Wissner A
    J Med Chem; 2005 Feb; 48(4):1107-31. PubMed ID: 15715478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Baylis-Hillman acetates in organic synthesis: convenient one-pot synthesis of α-carboline framework--a concise synthesis of neocryptolepine.
    Basavaiah D; Mallikarjuna Reddy D
    Org Biomol Chem; 2012 Nov; 10(44):8774-7. PubMed ID: 23070215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and in vitro anticancer activity of 6,7-methylenedioxy (or 5-hydroxy-6-methoxy)-2-(substituted selenophenyl)quinolin-4-one analogs.
    Chen CT; Hsu MH; Cheng YY; Liu CY; Chou LC; Huang LJ; Wu TS; Yang X; Lee KH; Kuo SC
    Eur J Med Chem; 2011 Dec; 46(12):6046-56. PubMed ID: 22030314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, antitumor evaluation and SAR of new 1H-pyrrolo [3,2-c] quinoline-6,9-diones and 11H-indolo [3,2-c] quinoline-1,4-diones.
    Helissey P; Cros S; Giorgi-Renault S
    Anticancer Drug Des; 1994 Feb; 9(1):51-67. PubMed ID: 8141966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A class of novel carboline intercalators: Their synthesis, in vitro anti-proliferation, in vivo anti-tumor action, and 3D QSAR analysis.
    Wu J; Li C; Zhao M; Wang W; Wang Y; Peng S
    Bioorg Med Chem; 2010 Sep; 18(17):6220-9. PubMed ID: 20692841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antitumor agents 253. Design, synthesis, and antitumor evaluation of novel 9-substituted phenanthrene-based tylophorine derivatives as potential anticancer agents.
    Wei L; Shi Q; Bastow KF; Brossi A; Morris-Natschke SL; Nakagawa-Goto K; Wu TS; Pan SL; Teng CM; Lee KH
    J Med Chem; 2007 Jul; 50(15):3674-80. PubMed ID: 17585747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and cytotoxic activity of novel quinazolino-beta-carboline-5-one derivatives.
    Baruah B; Dasu K; Vaitilingam B; Mamnoor P; Venkata PP; Rajagopal S; Yeleswarapu KR
    Bioorg Med Chem; 2004 May; 12(9):1991-4. PubMed ID: 15080902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.